Gauss Surgical wins CE Mark for Triton blood loss monitor

Gauss Surgical said it won CE Mark approval in the European Union for its Triton mobile real-time surgical blood loss monitoring system.

The device works with Apple‘s (NSDQ:AAPL) iPad system and is the 1st and only mobile platform for surgical blood loss monitoring, the Los Altos, Calif.-based company said.

“We have had a strong response to our technology to date in the United States. While our immediate commercial focus remains in the U.S., receiving the CE Mark is an important step towards enabling medical facilities throughout Europe to adopt our solution. Blood management is indeed a worldwide healthcare priority, and we are eager to ultimately bring the benefits of real-time blood loss monitoring to bear on a global scale,” CEO Dr. Milton McColl said in a press release.

The company’s device and software helps reduce unnecessary transfusions by scanning surgical sponges and blood bearing canisters where image-proessing algorithms estimate the amount of blood contained in them.

In August, Gauss Surgical said it raised $3.3 million and is looking to raise $600,000 more in a new round of equity financing, according to an SEC filing.

The system was FDA cleared for sponge blood loss calculation in May 2014, and won 510(k) clearance for suction container blood loss calculation in March this year.

The post Gauss Surgical wins CE Mark for Triton blood loss monitor appeared first on MassDevice.

from MassDevice http://ift.tt/1HrNwou